Hong Kong Operating Income Over Time
| HKPD Stock | 0.83 0.02 2.47% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Hong Kong Performance and Hong Kong Correlation. Will Air Freight & Logistics sector continue expanding? Could Hong diversify its offerings? Factors like these will boost the valuation of Hong Kong. Market participants price Hong higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Hong Kong data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.302 | Revenue Per Share | Quarterly Revenue Growth (0.05) | Return On Assets | Return On Equity |
The market value of Hong Kong Pharma is measured differently than its book value, which is the value of Hong that is recorded on the company's balance sheet. Investors also form their own opinion of Hong Kong's value that differs from its market value or its book value, called intrinsic value, which is Hong Kong's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Hong Kong's market value can be influenced by many factors that don't directly affect Hong Kong's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hong Kong's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hong Kong is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Hong Kong's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Income Analysis
Compare Hong Kong Pharma and related stocks such as Lakeside Holding, PS International, and Freightos Limited Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LSH | 117.8 K | 117.8 K | 117.8 K | 117.8 K | 117.8 K | 117.8 K | 117.8 K | 117.8 K | 117.8 K | 117.8 K | 117.8 K | 117.8 K | (246.9 K) | (526 K) | (5 M) | (4.5 M) | (4.2 M) |
| PSIG | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 14.9 M | (824.7 K) | 6 M | (5.3 M) | (4.7 M) | (4.5 M) |
| CRGO | (12.9 M) | (12.9 M) | (12.9 M) | (12.9 M) | (12.9 M) | (12.9 M) | (12.9 M) | (12.9 M) | (12.9 M) | (12.9 M) | (12.9 M) | (16.3 M) | (25 M) | (77.8 M) | (22.9 M) | (20.7 M) | (21.7 M) |
| UUU | 600 K | (1.4 M) | (1.2 M) | (2 M) | (2.6 M) | (1.4 M) | (978.1 K) | (726.2 K) | 186.9 K | (1.6 M) | 133.8 K | 69.7 K | 972.6 K | (564.8 K) | 402 K | 361.8 K | 379.9 K |
| NCEW | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 6.6 M | 8.2 M | 522.5 K | 470.3 K | 470.3 K | 423.2 K | 402.1 K |
| JYD | 6.3 M | 6.3 M | 6.3 M | 6.3 M | 6.3 M | 6.3 M | 6.3 M | 6.3 M | 6.3 M | 6.3 M | 6.3 M | 12.8 M | 702.2 K | (79.8 M) | (52.1 M) | (46.9 M) | (44.6 M) |
| TLIH | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 6.3 M | 8.2 M | 2.8 M | 3.2 M | 5.4 M |
| VRME | (1.4 M) | (340 K) | (1.1 M) | (11.6 M) | (13.6 M) | (5.2 M) | (3.7 M) | (2.8 M) | (2.6 M) | (2.4 M) | (3.6 M) | (4.8 M) | (3.7 M) | (3.2 M) | (2.1 M) | (1.9 M) | (2 M) |
| ARTW | (500 K) | 4.3 M | 1.8 M | 1.7 M | (76.8 K) | (431.4 K) | (1.7 M) | (3.1 M) | (1.5 M) | (3.9 M) | 523.4 K | 604.7 K | 1.5 M | 460.7 K | 289 K | 260.1 K | 508.9 K |
| ATXG | 190 | 190 | 190 | 190 | 190 | (9.7 K) | 66.8 K | (256 K) | (683.1 K) | (864.3 K) | (3.6 M) | (57 K) | (462.9 K) | (1.1 M) | (1.8 M) | 66.8 K | 70.1 K |
Hong Kong Pharma and related stocks such as Lakeside Holding, PS International, and Freightos Limited Operating Income description
Operating Income is the amount of profit realized from Hong Kong Pharma operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Hong Kong Pharma is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Hong Kong Pharma | HKPD |
Specialization | Industrials, Pharmaceutical Retailers |
| Business Address | Well Town Industrial |
| Exchange | NASDAQ Exchange |
null 0.83
Check out Hong Kong Performance and Hong Kong Correlation. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Hong Kong technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.